Freedom is often discussed in emotional or cultural terms, but for many people, it is deeply financial. Nowhere is that more ...

A newly approved drug gives almost total protection against getting HIV. The FDA approved lenacapavir last week. Patients need just two injections of it a year to get that protection, but as NPR's ...

Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...

PALM SPRINGS, Calif. (KESQ)- Promising signs in the fight against the HIV epidemic. But officials warn cuts to public health funding could reverse this progress. Director of specialty services at DAP ...

Frank Gupton, CEO of Medicines for All, said he hopes that will lead to production facilities closer to those high need areas like sub-Saharan Africa.

Gilead Sciences Inc (NASDAQ:GILD) is facing mounting pressure to price its long-acting HIV prevention drug, lenacapavir, affordably as it prepares for U.S. regulatory approval on June 19. In December ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The Supreme Court heard oral arguments last month in a case that ...

The fight to end HIV in our lifetimes just received a game-changing innovation. In June, the FDA approved Yeztugo (lenacapavir), a groundbreaking HIV prevention treatment that requires just two ...

A little over two decades ago, addressing Nigeria’s HIV crisis topped U.S. President George W. Bush’s priorities. Africa’s most populous nation had 3.5 million HIV cases, and the disease threatened to ...

Eight times more American young adults now take medication to protect them from HIV than a decade ago, a new study finds. But even with this positive news about increasing use of pre-exposure ...